Immunogen Inc (DELISTED) (IMGN:DL)
31.23
0.00 (0.00%)
USD |
NASDAQ |
Feb 13, 16:00
Immunogen Total Liabilities (Quarterly): 260.50M for Sept. 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 260.50M |
| June 30, 2023 | 223.48M |
| March 31, 2023 | 166.43M |
| December 31, 2022 | 193.11M |
| September 30, 2022 | 180.79M |
| June 30, 2022 | 172.46M |
| March 31, 2022 | 175.24M |
| December 31, 2021 | 200.18M |
| September 30, 2021 | 219.71M |
| June 30, 2021 | 232.98M |
| March 31, 2021 | 251.84M |
| December 31, 2020 | 265.50M |
| September 30, 2020 | 290.84M |
| June 30, 2020 | 294.25M |
| March 31, 2020 | 302.91M |
| December 31, 2019 | 311.38M |
| September 30, 2019 | 340.36M |
| June 30, 2019 | 355.84M |
| March 31, 2019 | 351.53M |
| December 31, 2018 | 284.41M |
| September 30, 2018 | 292.98M |
| June 30, 2018 | 291.89M |
| March 31, 2018 | 301.28M |
| December 31, 2017 | 312.57M |
| September 30, 2017 | 336.99M |
| Date | Value |
|---|---|
| June 30, 2017 | 354.61M |
| March 31, 2017 | 330.85M |
| September 30, 2016 | 353.89M |
| June 30, 2016 | 361.54M |
| March 31, 2016 | 263.49M |
| December 31, 2015 | 268.27M |
| September 30, 2015 | 273.98M |
| June 30, 2015 | 273.14M |
| March 31, 2015 | 74.13M |
| December 31, 2014 | 51.07M |
| September 30, 2014 | 84.14M |
| June 30, 2014 | 89.62M |
| March 31, 2014 | 88.76M |
| December 31, 2013 | 72.49M |
| September 30, 2013 | 80.58M |
| June 30, 2013 | 91.75M |
| March 31, 2013 | 89.68M |
| December 31, 2012 | 94.84M |
| September 30, 2012 | 95.36M |
| June 30, 2012 | 96.42M |
| March 31, 2012 | 95.40M |
| December 31, 2011 | 92.88M |
| September 30, 2011 | 75.33M |
| June 30, 2011 | 77.67M |
| March 31, 2011 | 77.50M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
166.43M
Minimum
Mar 2023
355.84M
Maximum
Jun 2019
246.55M
Average
242.41M
Median
Total Liabilities (Quarterly) Benchmarks
| AbbVie Inc | 124.31B |
| Pfizer Inc | 137.21B |
| Johnson & Johnson | 101.95B |
| Merck & Co Inc | 69.04B |
| Cerevel Therapeutics Holdings Inc | 569.55M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 822.10M |
| Shareholders Equity (Quarterly) | 561.60M |
| Debt to Equity Ratio | 0.1284 |
| Current Ratio | 5.695 |
| Net Debt Paydown Yield | -0.34% |